T2D patients are associated with decreased PBMC expression of mir-146a, which is correlated with IR, poor glycemic control, and expression of several pro-inflammatory genes with increased plasma levels of TNF-α and IL-6 [107]. This evidence concerns the gene IL6 and type 2 diabetes mellitus.